To start this activity, click Begin at the bottom of this page
Release Date: March 2014
Expiration Date: March 2015
Estimated time to complete the educational activity: 30 minutes
Program Description: From the March 2014 issue of The Clinical Advisor: An understanding of
substance use disorder
. Effective treatment requires the recognition of addiction as a brain disease and an understanding of its underlying physiology and pathophysiology.
Target Audience: This activity has been designed to meet the educational needs of primary-care physicians, physician assistants, and nurse practitioners who treat patients with substance use disorder.
Learning Objectives: After completing the activity, the participant should be better able to:
- Name the major structures of the brain’s reward pathway.
- Describe the role that dopamine plays in the process of addiction.
- Demonstrate how substance use disorders are diagnosed using DSM-5 criteria.
- List the common signs and symptoms of opioid and alcohol withdrawal.
- Review the evidence-based screening tools used to determine the presence of a substance use disorder.
|Credits||Type||Accreditation Statement||Designation Statement|
AMA PRA Category 1 Credit(s)TM
Medical Education Resources designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 0.50 contact hours of continuing nursing education. Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 0.50 contact hours.
Mary Atkinson Smith, DNP, FNP-BC
Starkville Orthopedic Clinic
Scott Hambleton, MD, FASAM
Mississippi Professionals Health Program
Publishing Staff Disclosures
The content managers, Joseph Kopcha and Nicole Blazek of Haymarket Medical Education, have disclosed that they have no relevant financial relationships or conflicts of interest relating directly or indirectly to this activity. Carman Ciervo, DO, acting on behalf of Medical Education Resources, has reported that he is on the Speakers’ Bureau for Sunovion Pharmaceuticals. Veronda K. Smith, FNP-BC, of Medical Education Resources, has no relationships to disclose related to the content of this article.
Method of Participation: There are no fees for participating in and receiving CMEcredit for this activity. During the period March 2014 through March 2015,participants must: 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest and submit it online and 4) complete the evaluation form online.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70% or better.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or Haymarket Medical. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources or Haymarket medical.
Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.